Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Opin Cardiol ; 2024 Jun 10.
Article in English | MEDLINE | ID: mdl-38847610

ABSTRACT

PURPOSE OF REVIEW: We aim to provide a comprehensive examination of the literature linking elevated rates of cardiovascular disease (CVD) in individuals of South Asian ethnicity with the severity of circulating vascular regenerative cell exhaustion. RECENT FINDINGS: Recent findings have demonstrated reduced bioavailability of pro-vascular progenitor cell subsets in individuals with T2D and obesity. Depletion of vascular regenerative cells in the bone marrow - coupled with decreased mobilization into circulation - can negatively impact the capacity for vascular repair and exacerbate CVD risk. Several recent studies have established that although South Asian individuals possess similar inflammatory cell burden compared with other ethnicities, they exhibit marked decreases in vessel regenerative hematopoietic progenitor cells and monocyte subsets. Validation of these findings and investigation the functional capacity of vascular regenerative cell subsets to mediate vessel repair is highly warranted. SUMMARY: Vascular regenerative cells play a key role coordinating angiogenic and arteriogenic vessel remodelling. Recent studies have demonstrated that South Asian individuals with T2D show severe depletion in circulating vascular regenerative cell subsets. Because the reversal of vascular regenerative cell exhaustion by current glucose-lowering pharmaceutical agents has recently been documented, early intervention to bolster vascular regenerative cell content may prevent CVD co-morbidities in South Asian individuals with cardiometabolic disease.

2.
Am J Physiol Heart Circ Physiol ; 326(5): H1159-H1176, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38426865

ABSTRACT

Atherosclerotic cardiovascular disease is a chronic condition that often copresents with type 2 diabetes and obesity. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are incretin mimetics endorsed by major professional societies for improving glycemic status and reducing atherosclerotic risk in people living with type 2 diabetes. Although the cardioprotective efficacy of GLP-1RAs and their relationship with traditional risk factors are well established, there is a paucity of publications that have summarized the potentially direct mechanisms through which GLP-1RAs mitigate atherosclerosis. This review aims to narrow this gap by providing comprehensive and in-depth mechanistic insight into the antiatherosclerotic properties of GLP-1RAs demonstrated across large outcome trials. Herein, we describe the landmark cardiovascular outcome trials that triggered widespread excitement around GLP-1RAs as a modern class of cardioprotective agents, followed by a summary of the origins of GLP-1RAs and their mechanisms of action. The effects of GLP-1RAs at each major pathophysiological milestone of atherosclerosis, as observed across clinical trials, animal models, and cell culture studies, are described in detail. Specifically, this review provides recent preclinical and clinical evidence that suggest GLP-1RAs preserve vessel health in part by preventing endothelial dysfunction, achieved primarily through the promotion of angiogenesis and inhibition of oxidative stress. These protective effects are in addition to the broad range of atherosclerotic processes GLP-1RAs target downstream of endothelial dysfunction, which include systemic inflammation, monocyte recruitment, proinflammatory macrophage and foam cell formation, vascular smooth muscle cell proliferation, and plaque development.


Subject(s)
Atherosclerosis , Endothelium, Vascular , Glucagon-Like Peptide-1 Receptor Agonists , Animals , Humans , Atherosclerosis/drug therapy , Atherosclerosis/prevention & control , Diabetes Mellitus, Type 2/drug therapy , Endothelium, Vascular/drug effects , Endothelium, Vascular/physiopathology , Incretins/therapeutic use , Signal Transduction
3.
J Exp Child Psychol ; 223: 105480, 2022 11.
Article in English | MEDLINE | ID: mdl-35753197

ABSTRACT

Adults are experts at recognizing familiar faces across images that incorporate natural within-person variability in appearance (i.e., ambient images). Little is known about children's ability to do so. In the current study, we investigated whether 4- to 7-year-olds (n = 56) could recognize images of their own parent-a person with whom children have had abundant exposure in a variety of different contexts. Children were asked to identify images of their parent that were intermixed with images of other people. We included images of each parent taken both before and after their child was born to manipulate how close the images were to the child's own experience. When viewing before-birth images, 4- and 5-year-olds were less sensitive to identity than were older children; sensitivity did not differ when viewing images taken after the child was born. These findings suggest that with even the most familiar face, 4- and 5-year-olds have difficulty recognizing instances that go beyond their direct experience. We discuss two factors that may contribute to the prolonged development of familiar face recognition.


Subject(s)
Facial Recognition , Adolescent , Adult , Child , Child, Preschool , Family , Humans , Parents
SELECTION OF CITATIONS
SEARCH DETAIL
...